Skip to main content
Top
Published in: Intensive Care Medicine 5/2003

01-05-2003 | Experimental

Streptococcus pneumoniae strain-dependent lung inflammatory responses in a murine model of pneumococcal pneumonia

Authors: Jacqueline Mohler, Esther Azoulay-Dupuis, Cécile Amory-Rivier, Jean Xavier Mazoit, Jean Pierre P. Bédos, Véronique Rieux, Pierre Moine

Published in: Intensive Care Medicine | Issue 5/2003

Login to get access

Abstract

Objective

The inherent properties of an invading bacterium may influence the cytokine profile that is ultimately produced. We determined the alterations in proinflammatory (TNF-α, IL-1, and IL-6) and anti-inflammatory cytokine (IL-10) expressions in lung tissues within the first 48 h after infection in mice with pneumonia induced by direct intratracheal inoculation of five different pneumococcal strains.

Design

Experimental murine model of Streptococcus pneumoniae pneumonia.

Subjects

Female BALB/cby mice aged 8–10 weeks.

Interventions

Five S. pneumoniae clinical isolates were used in this study. The strains included two serotype 3 strains (P4241 and P30606), two serotype 6 strains (P26772 and P23477), and one serotype 19 strain (P15986). The trachea of anesthetized animals was cannulated via the mouth with a blunt needle, and 50 µl bacterial suspension of two different inocula (their respective 100% lethal inoculum and the same 105 CFU/mouse inoculum of S. pneumoniae strains) were instillated. At predetermined times after pneumococcal infection, i.e., time 0 (preinfection) and 2, 4, 6, 12, 24, and 48 h postinfection in experimental groups, lung tissues were sampled from groups of three mice to quantify lung pro- and anti-inflammatory mediators. The experiments were repeated at least three times.

Results

Pneumonia induced by five different pneumococcal isolates resulted in pronounced differences in the local pro- and anti-inflammatory profiles. For example, with a 100% lethal inoculum of S. pneumoniae, the extent and timing of TNF-α expression varied greatly among strains, ranging from 2,643 to 10,022 pg/g and from 4 to 48 h, respectively. Moreover, TNF-α productions within 48 h postinfection measured by the 48 h area under the curve were differed significantly, ranging from 59,700 to 275,825. These different profiles were not serotype dependent. Comparable results were obtained when IL-1, IL-6, and IL-10 expressions in lung tissues were studied.

Conclusions

These findings confirm that the production of the pro- and anti-inflammatory mediators are critically dependent not only upon the different species of bacteria used to establish the experimental infection but also upon the different strains of a specific bacterial species used, i.e., S. pneumoniae in this study. These substantially different host responses were not serotype dependent. Moreover, the profile of lung pro-and anti-inflammatory cytokines within 48 h postinfection, at least in this pneumonia model, was not related to outcome of animals.
Literature
1.
go back to reference Bartlett JG, Breiman RF, Mandell LA, File TMJ (1998) Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 26:811–838CrossRef Bartlett JG, Breiman RF, Mandell LA, File TMJ (1998) Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 26:811–838CrossRef
2.
go back to reference Moine P, Vercken JB, Chevret S, Chastang C, Gajdos P, and The French Study Group for Community-Acquired Pneumonia in the Intensive Care Unit (1994) Severe community-acquired pneumonia. Etiology, epidemiology and prognosis factors. Chest 105:1487–1495CrossRef Moine P, Vercken JB, Chevret S, Chastang C, Gajdos P, and The French Study Group for Community-Acquired Pneumonia in the Intensive Care Unit (1994) Severe community-acquired pneumonia. Etiology, epidemiology and prognosis factors. Chest 105:1487–1495CrossRef
3.
go back to reference Örtqvist A, Hedlund J, Grillner L, Jalonem E, Kallings I, Leinomen M, Kallin M (1990) Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur Respir J 3:1105–1113PubMed Örtqvist A, Hedlund J, Grillner L, Jalonem E, Kallings I, Leinomen M, Kallin M (1990) Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur Respir J 3:1105–1113PubMed
4.
go back to reference Torres A, Serra-Battles J, Ferrer A, Jimenéz P, Celis R, Cobo E, Rodriguez-Roisin R (1991) Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis 144:312–318CrossRef Torres A, Serra-Battles J, Ferrer A, Jimenéz P, Celis R, Cobo E, Rodriguez-Roisin R (1991) Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis 144:312–318CrossRef
5.
go back to reference Johnston RBJ (1991) Pathogenesis of pneumococcal pneumonia. Rev Infect Dis 13 [Suppl 6]:S509–S517 Johnston RBJ (1991) Pathogenesis of pneumococcal pneumonia. Rev Infect Dis 13 [Suppl 6]:S509–S517
6.
go back to reference Houldsworth S, Andrew PW, Mitchell TJ (1994) Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes. Infect Immun 62:1501–1503PubMedPubMedCentral Houldsworth S, Andrew PW, Mitchell TJ (1994) Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes. Infect Immun 62:1501–1503PubMedPubMedCentral
7.
go back to reference Riesenfeld-Orn I, Wolpe S, Garcia-Bustos JF, Hoffmann MK, Tuomanen E (1989) Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components. Infect Immun 57:1890–1893PubMedPubMedCentral Riesenfeld-Orn I, Wolpe S, Garcia-Bustos JF, Hoffmann MK, Tuomanen E (1989) Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components. Infect Immun 57:1890–1893PubMedPubMedCentral
8.
go back to reference Simpson SQ, Singh R, Brice DE (1994) Heat-killed pneumococci and pneumococcal capsular polysaccharides stimulate tumor necrosis factor-α production by murine macrophages. Am J Respir Cell Mol Biol 10:284–289CrossRef Simpson SQ, Singh R, Brice DE (1994) Heat-killed pneumococci and pneumococcal capsular polysaccharides stimulate tumor necrosis factor-α production by murine macrophages. Am J Respir Cell Mol Biol 10:284–289CrossRef
9.
go back to reference Spellerberg B, Rosenow C, Sha W, Tuomanen E (1996) Pneumococcal cell wall activates NF-κB in human monocytes: aspects distinct from endotoxin. Microb Pathog 20:309–317CrossRef Spellerberg B, Rosenow C, Sha W, Tuomanen E (1996) Pneumococcal cell wall activates NF-κB in human monocytes: aspects distinct from endotoxin. Microb Pathog 20:309–317CrossRef
10.
go back to reference Bergeron Y, Ouellet N, Deslauriers A, Simard M, Olivier M, Bergeron MG (1998) Cytokine kinetics and other factors in response to pneumococcal pulmonary infection in mice. Infect Immun 66:912–922PubMedPubMedCentral Bergeron Y, Ouellet N, Deslauriers A, Simard M, Olivier M, Bergeron MG (1998) Cytokine kinetics and other factors in response to pneumococcal pulmonary infection in mice. Infect Immun 66:912–922PubMedPubMedCentral
11.
go back to reference Takashima K, Tateda K, Matsumoto T, Iizawa Y, Nakao M, Yamaguchi K (1997) Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice. Infect Immun 65:257–260PubMedPubMedCentral Takashima K, Tateda K, Matsumoto T, Iizawa Y, Nakao M, Yamaguchi K (1997) Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice. Infect Immun 65:257–260PubMedPubMedCentral
12.
go back to reference Van Der Poll T, Keogh CV, Buurman WA, Lowry SF (1997) Passive immunization against tumor necrosis factor-α impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med 155:603–608CrossRef Van Der Poll T, Keogh CV, Buurman WA, Lowry SF (1997) Passive immunization against tumor necrosis factor-α impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med 155:603–608CrossRef
13.
go back to reference Gordon DL, Hostetter MK (1986) Complement and host defense against microorganisms. Pathology 18:365–375CrossRef Gordon DL, Hostetter MK (1986) Complement and host defense against microorganisms. Pathology 18:365–375CrossRef
14.
go back to reference Gordon DL, Johnson GM, Hostetter MK (1986) Ligand-receptor interactions in the phagocytosis of virulent Streptococcus pneumoniae by polymorphonuclear leukocytes. J Infect Dis 154:619–626CrossRef Gordon DL, Johnson GM, Hostetter MK (1986) Ligand-receptor interactions in the phagocytosis of virulent Streptococcus pneumoniae by polymorphonuclear leukocytes. J Infect Dis 154:619–626CrossRef
15.
go back to reference Casadevall A, Pirofski LA (1999) Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun 67:3703–3713PubMedPubMedCentral Casadevall A, Pirofski LA (1999) Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun 67:3703–3713PubMedPubMedCentral
16.
go back to reference Azoulay-Dupuis E, Rieux V, Muffat-Joly M, Bedos JP, Vallee E, Rivier C, Isturiz R, Carbon C, Moine P (2000) Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice. Antimicrob Agents Chemother 44:1575–1577CrossRef Azoulay-Dupuis E, Rieux V, Muffat-Joly M, Bedos JP, Vallee E, Rivier C, Isturiz R, Carbon C, Moine P (2000) Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice. Antimicrob Agents Chemother 44:1575–1577CrossRef
17.
go back to reference Moine P, Vallee E, Azoulay-Dupuis E, Bourget P, Bedos JP, Bauchet J, Pocidalo JJ (1994) In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob Agents Chemother 38:1953–1958CrossRef Moine P, Vallee E, Azoulay-Dupuis E, Bourget P, Bedos JP, Bauchet J, Pocidalo JJ (1994) In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob Agents Chemother 38:1953–1958CrossRef
18.
go back to reference Amory-Rivier CF, Mohler J, Bedos JP, Azoulay-Dupuis E, Henin D, Muffat-Joly M, Carbon C, Moine P (2000) Nuclear factor-kappaB activation in mouse lung lavage cells in response to Streptococcus pneumoniae pulmonary infection. Crit Care Med 28:3249–3256CrossRef Amory-Rivier CF, Mohler J, Bedos JP, Azoulay-Dupuis E, Henin D, Muffat-Joly M, Carbon C, Moine P (2000) Nuclear factor-kappaB activation in mouse lung lavage cells in response to Streptococcus pneumoniae pulmonary infection. Crit Care Med 28:3249–3256CrossRef
19.
go back to reference Azoulay-Dupuis E, Bedos JP, Vallee E, Pocidalo JJ (1991) Comparative activity of fluorinated quinolones in acute and subacute Streptococcus pneumoniae pneumonia models: efficacy of temafloxacin. J Antimicrob Chemother 28 Suppl C:45–53CrossRef Azoulay-Dupuis E, Bedos JP, Vallee E, Pocidalo JJ (1991) Comparative activity of fluorinated quinolones in acute and subacute Streptococcus pneumoniae pneumonia models: efficacy of temafloxacin. J Antimicrob Chemother 28 Suppl C:45–53CrossRef
20.
go back to reference Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE, Standiford TJ (1995) Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol 155:722–729PubMed Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE, Standiford TJ (1995) Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol 155:722–729PubMed
21.
go back to reference Laichalk LL, Kunkel SL, Strieter RM, Danforth JM, Bailie MB, Standiford TJ (1996) Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect Immun 64:5211–18PubMedPubMedCentral Laichalk LL, Kunkel SL, Strieter RM, Danforth JM, Bailie MB, Standiford TJ (1996) Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect Immun 64:5211–18PubMedPubMedCentral
22.
go back to reference Chernick MR (1999) Bootstrap methods. A practitioner's guide. Willey, New York Chernick MR (1999) Bootstrap methods. A practitioner's guide. Willey, New York
23.
go back to reference Tuomanen E, Rich R, Zak O (1987) Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am Rev Respir Dis 135:869–874CrossRef Tuomanen E, Rich R, Zak O (1987) Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am Rev Respir Dis 135:869–874CrossRef
24.
go back to reference Dehoux MS, Boutten A, Ostinelli J, Seta N, Dombret MC, Crestani B, Deschenes M, Trouillet JL, Aubier M (1994) Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 150:710–716CrossRef Dehoux MS, Boutten A, Ostinelli J, Seta N, Dombret MC, Crestani B, Deschenes M, Trouillet JL, Aubier M (1994) Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 150:710–716CrossRef
25.
go back to reference Van der Poll T, Keogh CV, Guirao X, et al (1997) Interleukin 6 gene-deficient mice are more susceptible to pneumococcal pneumonia. J Infect Dis 176:439–444CrossRef Van der Poll T, Keogh CV, Guirao X, et al (1997) Interleukin 6 gene-deficient mice are more susceptible to pneumococcal pneumonia. J Infect Dis 176:439–444CrossRef
26.
go back to reference Hessle C, Andersson B, Wold AE (2000) Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect Immun 68:3581–3586CrossRef Hessle C, Andersson B, Wold AE (2000) Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect Immun 68:3581–3586CrossRef
27.
go back to reference Jiang Y, Magli L, Russo M (1999) Bacterium-dependent induction of cytokines in mononuclear cells and their pathologic consequences in vivo. Infect Immun 67:2125–2130PubMedPubMedCentral Jiang Y, Magli L, Russo M (1999) Bacterium-dependent induction of cytokines in mononuclear cells and their pathologic consequences in vivo. Infect Immun 67:2125–2130PubMedPubMedCentral
28.
go back to reference Silverstein R, Norimatsu M, Morrison DC (1997) Fundamental differences during gram-positive versus gram-negative sepsis become apparent during bacterial challenge of D-galactosamide-treated mice. J Endotoxin Res 4:173–181CrossRef Silverstein R, Norimatsu M, Morrison DC (1997) Fundamental differences during gram-positive versus gram-negative sepsis become apparent during bacterial challenge of D-galactosamide-treated mice. J Endotoxin Res 4:173–181CrossRef
29.
go back to reference Ingalls RR, PA Rice, Qureshi N, Takayama K, Lin JS, Golenbock DT (1995) The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect Immun 63:3125–3130PubMedPubMedCentral Ingalls RR, PA Rice, Qureshi N, Takayama K, Lin JS, Golenbock DT (1995) The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect Immun 63:3125–3130PubMedPubMedCentral
30.
go back to reference Jotwani R, Tanaka Y, Watanabe K, Tanaka-Bandoh K, Kato N, Ueno K (1994) Comparison of cytokine induction by lipopolysaccharide of Bacteroides fragilis with Salmonella typhimurium in mice. Microbiol Immunol 38:763–766CrossRef Jotwani R, Tanaka Y, Watanabe K, Tanaka-Bandoh K, Kato N, Ueno K (1994) Comparison of cytokine induction by lipopolysaccharide of Bacteroides fragilis with Salmonella typhimurium in mice. Microbiol Immunol 38:763–766CrossRef
31.
go back to reference Cavaillon JM, Cavaillon NH (1987) Characterization of the induction of human interleukin-1 by endotoxins. In: Brequet P (ed) Lipid mediators in the immunology of burn and sepsis. Plenum, London Cavaillon JM, Cavaillon NH (1987) Characterization of the induction of human interleukin-1 by endotoxins. In: Brequet P (ed) Lipid mediators in the immunology of burn and sepsis. Plenum, London
32.
go back to reference Zughaier SM, Ryley HC, Jackson SK (1999) Lipopolysaccharides (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonoas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Infect Immun 67:1505–1507PubMedPubMedCentral Zughaier SM, Ryley HC, Jackson SK (1999) Lipopolysaccharides (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonoas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Infect Immun 67:1505–1507PubMedPubMedCentral
33.
go back to reference Koyama S, Sato E, Nomura H, Kubo K, Miura M, Yamashita T, Nagai S, Izumi T (2000) The potential of various lipopolysaccharides to release IL-8 and G-CSF. Am J Physiol Lung Cell Mol Physiol 278:L658–L666CrossRef Koyama S, Sato E, Nomura H, Kubo K, Miura M, Yamashita T, Nagai S, Izumi T (2000) The potential of various lipopolysaccharides to release IL-8 and G-CSF. Am J Physiol Lung Cell Mol Physiol 278:L658–L666CrossRef
34.
go back to reference Engelhard D, Pomeranz S, Gallily R, Strauss N, Tuomanen E (1997) Serotype-related differences in inflammatory response to Streptococcus pneumoniae in experimental meningitis. J Infect Dis 175:979–982CrossRef Engelhard D, Pomeranz S, Gallily R, Strauss N, Tuomanen E (1997) Serotype-related differences in inflammatory response to Streptococcus pneumoniae in experimental meningitis. J Infect Dis 175:979–982CrossRef
35.
go back to reference Polissi A, Pontiggia A, Feger G, Altieri M, Mottl H, Ferrari L, Simon D (1998) Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect Immun 66:5620–5629PubMedPubMedCentral Polissi A, Pontiggia A, Feger G, Altieri M, Mottl H, Ferrari L, Simon D (1998) Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect Immun 66:5620–5629PubMedPubMedCentral
36.
go back to reference Hava DL, Camilli A (2002) Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 45:1389–1405PubMedPubMedCentral Hava DL, Camilli A (2002) Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 45:1389–1405PubMedPubMedCentral
37.
go back to reference Marchant A, Deviere J, Byl B, de Groote D, Vincent JL, Goldman M (1994) Interleukin-10 production during septicemia. Lancet 343:707–708CrossRef Marchant A, Deviere J, Byl B, de Groote D, Vincent JL, Goldman M (1994) Interleukin-10 production during septicemia. Lancet 343:707–708CrossRef
38.
go back to reference Derkx B, Marchant A, Goldman M, Bijlmer R, van Deventer S (1955) High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J Infect Dis 171:229–232CrossRef Derkx B, Marchant A, Goldman M, Bijlmer R, van Deventer S (1955) High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J Infect Dis 171:229–232CrossRef
39.
go back to reference Van Der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF (1996) Iterleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 174:994–1000CrossRef Van Der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF (1996) Iterleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 174:994–1000CrossRef
40.
go back to reference Marchant A, Bruyns C, Vandenabeele P, Ducarme M, Gerard C, Delvaux A, De Groote D, Abramowicz D, Velu T, Goldman M (1994) IL-10 controls IFN-g and TNF production during experimental endotoxinemia. Eur J Immunol 24:1167–1171CrossRef Marchant A, Bruyns C, Vandenabeele P, Ducarme M, Gerard C, Delvaux A, De Groote D, Abramowicz D, Velu T, Goldman M (1994) IL-10 controls IFN-g and TNF production during experimental endotoxinemia. Eur J Immunol 24:1167–1171CrossRef
41.
go back to reference Florquin S, Amraoui Z, Abramowicz D, Goldman M (1994) Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J Immunol 153:2618–2623PubMed Florquin S, Amraoui Z, Abramowicz D, Goldman M (1994) Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J Immunol 153:2618–2623PubMed
42.
go back to reference Poll T van der, Marchant A, Buurman WA, Berman L, Keogh CV, Lazarus DD, Nguyen L, Goldman M, Moldawer LL, Lowry SF (1995) Endogenous interleukin 10 protects mice from death during septic peritonitis. J Immunol 155:5397–5401PubMed Poll T van der, Marchant A, Buurman WA, Berman L, Keogh CV, Lazarus DD, Nguyen L, Goldman M, Moldawer LL, Lowry SF (1995) Endogenous interleukin 10 protects mice from death during septic peritonitis. J Immunol 155:5397–5401PubMed
43.
go back to reference Poll T van der, Jansen J, Levi M, ten Cate H, ten Cate JW, van Deventer SJH (1994) Regulation of interleukin-10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med 180:1985–1988CrossRef Poll T van der, Jansen J, Levi M, ten Cate H, ten Cate JW, van Deventer SJH (1994) Regulation of interleukin-10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med 180:1985–1988CrossRef
Metadata
Title
Streptococcus pneumoniae strain-dependent lung inflammatory responses in a murine model of pneumococcal pneumonia
Authors
Jacqueline Mohler
Esther Azoulay-Dupuis
Cécile Amory-Rivier
Jean Xavier Mazoit
Jean Pierre P. Bédos
Véronique Rieux
Pierre Moine
Publication date
01-05-2003
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 5/2003
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-003-1699-x

Other articles of this Issue 5/2003

Intensive Care Medicine 5/2003 Go to the issue